Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Possible effects of anti-inter...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Possible effects of anti-interleukin-17 agents on erythrodermic psoriasis with thymoma: A case report

Bibliographic Details
Published in:JAAD Case Reports
Main Authors: Qiuyu Jia, MD, PhD, Jian Hu, MD, PhD, Jianzhong Zhang, MD, Xiaojie Wang, MD, PhD, Houmin Li, MD, PhD
Format: Article
Language:English
Published: Elsevier 2025-10-01
Subjects:
anti-interleukin-17 agents
erythrodermic psoriasis
myasthenia gravis
secukinumab
thymoma
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512624000730
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2352512624000730

Similar Items

  • Biologic anti-IL17 drugs in erythrodermic psoriasisCapsule Summary
    by: Alessandro Falco, MD, et al.
    Published: (2024-09-01)
  • Video-assisted thoracoscopic surgery for myasthenia gravis with thymoma: A six-year single-center experience
    by: Truong Giang Nguyen, Assoc.Prof., MD., PhD, et al.
    Published: (2021-01-01)
  • Efficacy and Safety of Adalimumab and Secukinumab in Erythrodermic Psoriasis: A Single Centre Retrospective Study
    by: Yachen Wang, et al.
    Published: (2025-07-01)
  • Treatment of Erythrodermic Psoriasis in Children with Secukinumab: A Case Report
    by: Lu X, et al.
    Published: (2023-07-01)
  • Herpetiform aphthous ulcerations induced by secukinumab: Report of 2 cases
    by: Michael Benzaquen, MD, et al.
    Published: (2020-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs